Leucocyte count is an indicator of carotid plaque instability in stroke patients
Abstract
Background/Aim. Increasing evidence points to the inflammatory character of atherosclerosis and several parameters of inflammation have been proposed as cerebrovascular risk markers. The objective of the research was to examine the connection of serum inflammatory parameters and ultrasound (US) characteristics of the structure and size of carotid plaque. We assumed that the number of leukocytes (Le) was an indicator of carotid plaque instability and an increased risk of stroke. Methods. Serum inflammatory parameters: erythrocyte sedimentation rate in the first (ESR I) and second hour (ESR II), the number of Le, high sensitivity C-reactive protein (hsCRP) and fibrinogen were measured by standard methods. All the subjects (n = 75) were divided into 3 groups (symptomatic, asymptomatic and control). US evaluation of extracranial carotid arteries was performed in a duplex system. Plaques were classified into categories according to stenosis percentage (≥ 50%, < 50%) and pursuant to echomorphological characteristics (Gray-Weale classification). In the subjects with stroke an ischemic lesion was confirmed by computed tomography. Results. The average values of biochemical parameters in the symptomatic group were: ESR I 29.57 ± 29.87 cm, ESR II 51.60 ± 36.87 cm, the number of Le 10.10 ± 3.20 ´ 10-9 U/L, hs-CRP 8.15 ± 5.50 mg/L and fibrinogen 4.03 ± 0.70 g/L. The average values of all testing biochemical parameters in symptomatic patients were significantly higher than in the asymptomatic ones and the control group: for ESR I (p < 0.05) and ESR II (p < 0.05); for the number of Le (p < 0.001); for hsCRP (p < 0.001) and fibrinogen (p < 0.001). Category I of echomorphological characteristics in the symptomatic group was present in 66.7% of the cases and it was significantly higher than in the asymptomatic (40.0%; p < 0.05) and the control group (20.0%; p < 0.01). Univariate logistic regression analysis confirmed that all testing biochemical parameters are indicators of stroke risk. Multivariate logistic regression analysis confirmed a statistically significant correlation of the number of Le and stroke risk, while the increase in the value by a unit of measurement was associated with the growth of risk by 3.22 times (from 1.67 to 6.22). Conclusion. The number of Le is associated with the phenomenon of carotid plaque instability and may be a useful additional marker of increased risk for developing acute cerebral infarction.
References
Davignon J, Ganz P. Role of Endothelial Dysfunction in Athe-rosclerosis. Circulation 2004; 109(23 Suppl 1): 27−32.
Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, et al. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation 2004; 109(21): 2617−25.
Morgan AR, Rerkasem K, Gallagher PJ, Zhang B, Morris GE, Calder PC, et al. Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics. Stroke 2004; 35(6): 1310−5.
Ministry of Health RS. National Guide. Belgrade: Ministry of Health of the Republic of Serbia 2004. (Serbian).
Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, et al. Carotid Artery Stenosis: Gray-Scale and Doppler US Diagnosis—Society of Radiologists in Ultra-sound Consensus Conference. Radiology 2003; 229(2): 340−6.
Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim Intima-Media Thickness Consen-sus (2004-2006-2011). Crebrovasc Dis 2012; 34(4): 290−6.
Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24(1): 35−41.
Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseas-es III. Stroke 1990; 21(4): 637−76.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16(1): 31−41.
Ding S, Zhang M, Zhao Y, Chen W, Yao G, Zhang C, et al. The role of carotid plaque vulnerability and inflammation in the pa-thogenesis of acute ischemic stroke. Am J Med Sci 2008; 336(1): 27−31.
Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007; 39(2): 175−91.
Uteyboogaart M, Schrijvers E, Vroomen P, Dekeyser J, Luijckx GJ. Routine Thrombolysis With Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke. Oxford J Med 2012; 36(5): 577−9.
Demarin V, Štikovac M, Thaller N. Blood-Vessel Doppler Ultra-sonography. Zagreb: Školska knjiga; 1990. (Croatian)
Gray-Weale AC, Graham JC, Burnett JR, Byrne K, Lusby RJ. Ca-rotid Artery Atheroma: Comparison of Preoperative B-mode Ultrasound Appearance With Carotid Endarterectomy Specimen Pathology. J Cardiovasc Surg 1988; 29(6): 676−81.
Chambless LE, Folsom AR, Davis V, Sharrett R, Heiss G, Sorlie P, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 2002; 155(1): 38−47.
Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004; 292(15): 1845−52.
Mathiesen EB, Bønaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromsø study. Circulation 2001; 103(17): 2171−5.
AbuRahma AF, Wulu JT, Crotty B. Carotid plaque ultrasonic heterogeneity and severity of stenosis. Stroke 2002; 33(7): 1772−5.
Yoshida K, Narumi O, Chin M, Inoue K, Tabuchi T, Oda K, et al. Characterization of Carotid Atherosclerosis and Detection of Soft Plaque with Use of Black-Blood MR Imaging. Am J Neu-roradiol 2008; 29(5): 868−74.
Ohara T, Toyoda K, Otsubo R, Nagatsuka K, Kubota Y, Yasaka M, et al. Eccentric stenosis of the carotid artery associated with ipsilateral cerebrovascular events. Am J Neuroradiol 2008; 29(6): 1200−3.
Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke 2009; 40(1): 77−85.
Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008; 54(1): 24−38.
Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysi-ology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 2007; 58(5): 513−22.
Yang W. High Red Blood Cell Distribution Width is Closely Associated With Risk of Carotid Artery Atherosclerosis in Pa-tients With Hypertension. Exp Clin Cardiol 2010; 15(3): 37−40.
Zaremba J, Skrobanski P, Losy J. Acute Ischaemic Increases the Erytrocyte Sedimentation Rate, Which Correlates With Early Brain Damage. Folia Morphol (Warsz) 2004; 63(4): 373−6.
Mauriello A, Sangiorgi G, Palmieri G, Virmani R, Holmes DR, Schwartz RS, et al. Hyperfibrinogenemia is associated with spe-cific histocytological composition and complications of athe-rosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation 2000; 101(7): 744−50.
Krupinski J, Tiru M, Font AM, Ahmed N, Sullivan M, Luque A, et al. Increased Tissue Factor, MMP-8 and D-dimer Expression in Diabetic Patients With Instable Advanced Carotid Atheros-clerosis. Vasc Health Risk Manag 2007; 3(4): 405−12.
Magyar MT, Szikszai Z, Balla J, Valikovics A, Kappelmayer J, Imre S, et al. Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers. Stroke 2003; 34(1): 58−63.
Paximadas SA, Pagoni SN, Pitsavos CE, Skoumas JN, Karagianni ET, Nikitopoulou PD, et al. The changes of fibrinogen and li-poprotein a levels after six months treatment with statins. Atherosclerosis Suppl 2001; 2(2): 99.
Sen S, Hinderliter A, Sen PK, Simmons J, LeGrys VA, Beck J, et al. Association of leukocyte count with progression of aortic atheroma in stroke/transient ischemic attack patients. Stroke 2007; 38(11): 2900−5.
Elkind MS, Sciacca R, Boden-Albala B, Homma S, di Tullio MR. Leukocyte count is associated with aortic arch plaque thick-ness. Stroke 2002; 33(11): 2587−92.
Temelkova-Kurktschiev T, Koehler C, Henkel E, Hanefeld M. Leuko-cyte count and fibrinogen are associated with carotid and femoral intima-media thickness in a risk population for diabetes. Cardiovasc Res 2002; 56(2): 277−83.
Libby P, Shi G. Mast cells as mediators and modulators of atherogenesis. Circulation 2007; 115(19): 2471−3.
Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001; 32(11): 2575−9.
Jander S, Sitzer M, Schumann R, Schroeter M, Siebler M, Steinmetz H, et al. Inflammation in High-Grade Carotid Stenosis : A Possible Role for Macrophages and T Cells in Plaque Destabilization. Stroke 1998; 29(8): 1625−30.
Hashimoto H, Kitagawa K, Hougaku H, Etani H, Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke 2004; 35(7): 1625−30.
Wardlaw JM, Farrall A, Armitage PA, Carpenter T, Chappell F, Doubal F, et al. Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke 2008; 39(4): 1327−32.
Willeit J, Kiechl S, Oberhollenzer F, Rungger G, Egger G, Bonora E, et al. Distinct Risk Profiles of Early and Advanced Atheroscle-rosis : Prospective Results From the Bruneck Study. Atherosc-ler Thromb Vasc Biol 2000; 20(2): 529−37.
Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, et al. C-Reactive Protein Is an Independent Predictor of the Rate of Increase in Early Carotid Atherosclerosis. Circulation 2001; 104(1): 63−7.
Ceulemans A, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, Mi-chotte Y. The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation 2010; 7(1): 74.
Libby P, Ridker PM, Maseri A. Inflammation and atherosclero-sis. Circulation 2002; 105(9): 1135−43.
Silva D, Albuquerque L, Narvaes L, Goldani M, Pereira G. C-Reactive Protein and Clinical Instability in Carotid Artery Ob-structive Disease. J Vasc Bras 2007; 6(2): 1−7.
Everett BM, Ridker PM. Using inflammatory biomarkers to guide lipid therapy. Curr Cardiovasc Risk Reports 2008; 2(1): 29−34.
Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High Serum C-Reactive Protein Level Is Not an Inde-pendent Predictor for Stroke: The Rotterdam Study. Circula-tion 2006; 114(15): 1591−8.
Winbeck K, Poppert H, Etgen T, Conrad B, Sander D. Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke. Stroke 2002; 33(10): 2459−64.
Laterza O, Modur V, Crimmins D, Olander J, Landt Y, Lee JM. Identification of Novel Brain Biomarkers. Clin Chem 2006; 52(9): 1713−21.
Taylor A, Kent S, Flaherty P, Coyle L, Markwood T, Vernalis M. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: A Randomized Trial Comparing the Effects of Atorvastatin and Pravastatin on Carotid Intima Medial Thickness. Circulation 2002; 106(16): 2055−60.
Kettani F, Dragomir A, Côté R, Roy L, Bérard A, Blais L, et al. Impact of a better adherence to antihypertensive agents on ce-rebrovascular disease for primary prevention. Stroke 2009; 40(1): 213−20.